Drug Shortage Report for APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN

Last updated on 2021-04-16 History
Report ID 125395
Drug Identification Number 02470780
Brand name APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Common or Proper name APO-TRI-PACK HP
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) LANSOPRAZOLE AMOXICILLIN CLARITHROMYCIN
Strength(s) 30MG 500MG 500MG
Dosage form(s) CAPSULE (DELAYED RELEASE) KIT CAPSULE TABLET
Route of administration ORAL ORAL
Packaging size 56 BLS
ATC code A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-11-30
Actual start date 2020-12-01
Estimated end date 2021-07-09
Actual end date
Shortage status Actual shortage
Updated date 2021-04-16
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-04-16 French Compare
v9 2021-04-16 English Compare
v8 2021-03-08 French Compare
v7 2021-03-08 English Compare
v6 2021-03-08 French Compare
v5 2021-03-08 English Compare
v4 2020-12-01 English Compare
v3 2020-10-01 French Compare
v2 2020-10-01 English Compare
v1 2020-10-01 English Compare